View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
No need to go searching all over for the latest information on new drugs, indications, medication errors and more. You can find the latest journal articles and CE activities from our 50+ nursing journals, plus get access to new drug information and patient teaching aids from Nursing2014 Drug Handbook, all right here!
(From Facts & Comparisons)
The FDA has approved solifenacin succinate 5 and 10 mg tablets, the generic equivalent to VESIcare, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The FDA has approved an expanded indication for Pradaxa (dabigatran etexilate mesylate) capsules to include the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for 5 to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated.
The FDA has approved an expanded indication for Kalbitor (ecallantide) to include the treatment of acute attacks of hereditary angioedema in patients 12 years of age and older.
The Nursing2014 Drug Handbook -- Find complete monographs for more than 900 generic and nearly 3,000 trade drugs—including essential details on 31 NEW drugs—with important nursing considerations for each and every one in the 34th edition of the Nursing2014 Drug Handbook.
Back to Top